Financials data is unavailable for this security.
View more
Year on year Enfusion Inc grew revenues 16.09% from 150.35m to 174.54m while net income improved from a loss of 7.65m to a gain of 6.03m.
Gross margin | 67.15% |
---|---|
Net profit margin | 2.38% |
Operating margin | 3.48% |
Return on assets | 3.92% |
---|---|
Return on equity | 5.54% |
Return on investment | 6.28% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Enfusion Inc fell by 26.94m. However, the company earned 25.63m from its operations for a Cash Flow Margin of 14.69%. In addition the company used 9.67m on investing activities and also paid 43.08m in financing cash flows.
Cash flow per share | 0.1404 |
---|---|
Price/Cash flow per share | 77.92 |
Book value per share | 0.5443 |
---|---|
Tangible book value per share | 0.5443 |
More ▼
Balance sheet in USDView more
Current ratio | 3.62 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 170.92%.
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | -62.30 |